TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Two patients whose care had faced insurance barriers received approval after escalating their cases to company executives, according to a MedPage Today report published October 8, 2026. The cases suggest executive outreach may draw attention, but they do not establish how often it works, and advocates say patients should not have to pursue extraordinary appeals to obtain care.
Two patients received insurance approval after taking care disputes to company leadership, according to a MedPage Today report published October 8, 2026. The cases, highlighted by former insurance executive Wendell Potter, show that contacting executives can bring attention to individual cases, but they do not establish how often the approach succeeds.
One case involved Elizabeth Nicholas, who was diagnosed with breast cancer at age 36. After months of treatment, her insurer refused to cover the type of chemotherapy recommended by her oncologist, according to the report. Nicholas had written about her insurance dispute in Vanity Fair the previous month and emailed the insurer’s CEO. She then received a message from the company’s chief scientific officer saying the treatment had been approved. The report does not identify the insurer or provide details about the approval terms.
The other case involved Donald E. Grant Jr., 49, who has severe congenital cervical stenosis. After an earlier two-level artificial disc replacement did not adequately decompress his spinal cord, he developed myelomalacia, the report said. A surgeon at Cedars-Sinai in California, Hyun Bae, MD, was scheduled to operate, but was outside Grant’s insurance network even though the other parts of the operation were covered.
Grant used Claimable, an AI-assisted appeal platform, to help prepare an 11-page appeal. It argued that his plan had no in-network surgeon with comparable qualifications, cited relevant regulations and asked the insurer not to use algorithms to decide his case. Grant sent the appeal to UnitedHealth Group’s CEO and copied company leaders, legislators and journalists. UnitedHealthcare approved the procedure with Bae at the in-network rate, according to the report.
Executive Appeals Can Reach Decision-Makers
The cases point to a possible route for patients whose disputes have not been resolved through ordinary channels: raising a case with senior company officials may prompt additional review. Potter told MedPage Today that large insurers have staff who handle high-profile matters brought to the C-suite or public relations teams. That may help explain why an executive email can attract attention, but it is not evidence that this route routinely changes coverage decisions.
The approach also has limits. Both patients did substantial work to document their cases, and Grant’s appeal drew on medical and legal arguments. Patients may not have the time, expertise or support to assemble similar submissions. The report presents two individual outcomes, not a comparison of success rates or proof that executive escalation caused approval in every respect.
For patients and clinicians, the story highlights the gap between formal appeal processes and the practical effort sometimes required to secure care. It also raises concerns about unequal access to escalation: people with help from clinicians, advocates, journalists or appeal tools may be better positioned to reach decision-makers than those facing the same dispute alone.
AI-assisted medical appeal platform
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Two Appeals Reached Insurers
Potter, a former insurance company executive, featured the cases in his Substack newsletter, Health Care Un-Covered. He told MedPage Today that when he worked at Cigna, cases receiving media attention were elevated. His account offers perspective on how some high-profile files may be handled inside insurers, but it is his description of company practices and does not establish that all insurers use the same process.
The two cases reached executives through different paths. Nicholas had written publicly about her experience before contacting her CEO. Grant assembled a detailed appeal with assistance from an AI-supported platform and copied several other recipients. In Grant’s case, the specific result reported was approval for the operation with Bae at the in-network rate; the article does not say that all elements of his broader dispute were resolved.
Potter said patients often do not know how to challenge denials. He suggested healthcare professionals may have an advantage because they understand the system and can help patients document their cases. But his recommendation to consider nontraditional escalation came with a warning about potential professional consequences for clinicians who repeatedly challenge insurers.
“You can be certain that at big insurance companies, there is a group of people around the CEO who are dedicated to high-profile cases and cases that are elevated to the C-suite or to the PR department — and they get special attention.”
— Wendell Potter, former insurance company executive, to MedPage Today
As an affiliate, we earn on qualifying purchases.
How Often Executive Appeals Succeed
The report describes two successful cases but does not provide a broader sample, a success rate or evidence that contacting a CEO was the sole reason either insurer changed course. It is also unclear how many similar emails receive no response, how long the review took in each case, or whether the decisions set any precedent for other patients.
Details about Nicholas’s insurer and the precise terms of her chemotherapy approval are not given. The report also does not describe UnitedHealthcare’s reasoning for approving Grant’s procedure, whether the company reviewed his appeal through a particular internal process, or whether other coverage disputes in his case remain open. Potter’s warning about possible network consequences for clinicians is a stated risk, not an outcome reported for either patient.
medical dispute documentation tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Formal Appeals and Insurer Responses
The report does not identify a scheduled follow-up, company policy change or regulatory action arising from the cases. Patients facing similar disputes will still need to check their plan’s appeal procedures and document the medical and coverage grounds for a challenge. The two examples suggest that executive outreach is one possible escalation, but they do not show that it replaces formal appeals or guarantees a favorable decision.
Further information from the insurers could clarify how the decisions were made and whether executive referrals followed standard review channels. For now, the central unresolved issue is whether these cases reflect a repeatable way to resolve disputes or exceptional outcomes that depended on detailed appeals and public attention.
As an affiliate, we earn on qualifying purchases.
Key Questions
What happened in the two cases?
According to MedPage Today, Elizabeth Nicholas received approval for recommended chemotherapy after emailing her insurer’s CEO. UnitedHealthcare approved Donald E. Grant Jr.’s surgery with an out-of-network surgeon at the in-network rate after he sent a detailed appeal to UnitedHealth Group’s CEO and copied others.
Does emailing an insurance CEO guarantee coverage?
No. The report describes two successful cases but provides no success rate or evidence that CEO outreach will change other coverage decisions.
What did Grant include in his appeal?
Grant used Claimable, an AI-assisted appeal platform, to help prepare an 11-page submission. It argued that his plan lacked an in-network surgeon with comparable qualifications, cited regulations and asked the insurer not to use algorithms to decide his case.
Could contacting an insurer’s leadership affect a doctor?
Potter warned that clinicians who frequently challenge insurers could risk irritating the company or being removed from its network. The report does not say that this happened to either patient’s doctor.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
